-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
January 01, 2003 - Sulfate 1 MG/ML Injection 1873977 Chondroitin Sulfates 40 MG/ML / Glucosamine hydrochloride 50 MG/ML … Sulfate 2 MG/ML Cartridge 197426 Acetaminophen 325 MG / butalbital 50 MG Oral Tablet F10.129 Alcohol … Sulfate 15 MG Extended Release Oral Tablet 240093 Acetaminophen 500 MG / butalbital 50 MG / Caffeine … Sulfate 100 MG Extended Release Oral Tablet 252745 Chondroitin Sulfates 200 MG / Glucosamine 250 MG … Sulfate 30 MG Extended Release Oral Tablet 253137 Chondroitin Sulfates 200 MG / Glucosamine Sulfate
-
cds.ahrq.gov/cdsconnect/artifact-type/calculator
July 20, 2018 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS%20for%20Repository.pdf
May 24, 2023 - Implemented in the Summary Interface – Part 2
Risk Considerations
§ Most Recent MME
– Elements: Morphine
-
cds.ahrq.gov/taxonomy/term/22481
November 03, 2018 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository.pdf
September 21, 2018 - Implemented in the Summary Interface – Part 2
Risk Considerations
▪ Most Recent MME
– Elements: Morphine
-
cds.ahrq.gov/sites/default/files/reports/CDS_Connect_Pain_Management_Environmental_Scan.pdf
December 01, 2017 - Tools and resources
What are the prominent tools and applications in this clinical domain (e.g.,
morphine … Order sets
have also been used to both reduce morphine dosing and direct prescribers toward non-opioid … Institute of Medicine
MAT Medication-Assisted Therapy
MIPS Merit-based Incentive Payment System
MME Morphine
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
December 01, 2018 - POPULATE Pain Management Summary
Risk Considerations:
• Morphine
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
September 01, 2018 - In addition, access to a patient’s morphine milligram equivalents (MME) was planned but not yet
implemented
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2023_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2023 - history of
overdose, history of substance use disorder, recent opioid taper, higher opioid dosages—
≥50 morphine
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Implementation_Guide_Pain_Management_Summary_1.pdf
September 01, 2022 - overdose (e.g., history of
overdose, history of substance use disorder, higher opioid dosages—≥ 50 morphine
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary508_with%202020%20updates%202.pdf
May 01, 2020 - overdose, history of substance use disorder, higher opioid dosages (greater than or equal
to [≥] 50 morphine
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary50810012018.pdf
December 01, 2018 - overdose, history of substance use disorder, higher opioid dosages (greater than or equal
to [≥] 50 morphine
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Implementation_Guide_Pain_Management_Summary.pdf
September 01, 2021 - overdose (e.g., history of
overdose, history of substance use disorder, higher opioid dosages—≥ 50 morphine
-
cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2018.pdf
January 01, 2018 - or others) might include performance optimizations, addition of other related concepts,
built-in morphine